Published in Hum Mol Genet on June 01, 2002
Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci (2009) 6.22
The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet (2005) 4.02
Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet (2003) 3.07
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74
Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia. Int J Dev Neurosci (2011) 1.56
Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Neuropsychopharmacology (2010) 1.47
Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry (2010) 1.30
Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet (2006) 1.29
Genomewide linkage scan for bipolar-disorder susceptibility loci among Ashkenazi Jewish families. Am J Hum Genet (2004) 1.29
Finding schizophrenia genes. J Clin Invest (2005) 1.28
Effects of cis-regulatory variation differ across regions of the adult human brain. Hum Mol Genet (2010) 1.27
Evaluating historical candidate genes for schizophrenia. Mol Psychiatry (2015) 1.26
Lack of GPR88 enhances medium spiny neuron activity and alters motor- and cue-dependent behaviors. Nat Neurosci (2012) 1.25
Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophr Res (2008) 1.22
Molecular modulation of prefrontal cortex: rational development of treatments for psychiatric disorders. Behav Neurosci (2011) 1.20
Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains. Biol Psychiatry (2011) 1.18
Altered gene expression in the superior temporal gyrus in schizophrenia. BMC Genomics (2008) 1.17
Analyzing schizophrenia by DNA microarrays. Biol Psychiatry (2011) 1.16
Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol (2010) 1.14
Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biol Psychiatry (2007) 1.10
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry (2002) 1.09
Generation and characterization of Rgs4 mutant mice. Mol Cell Biol (2005) 1.08
Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology (2008) 1.07
Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin. Proc Natl Acad Sci U S A (2006) 1.06
Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol (2008) 1.06
Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr Bull (2008) 1.03
Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet (2004) 1.03
Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. Neural Plast (2013) 1.01
Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol Psychiatry (2006) 1.00
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
Schizophrenia: neural mechanisms for novel therapies. Mol Med (2003) 0.98
Drosophila, a genetic model system to study cocaine-related behaviors: a review with focus on LIM-only proteins. Neuropharmacology (2008) 0.95
Positive selection within the Schizophrenia-associated GABA(A) receptor beta(2) gene. PLoS One (2007) 0.95
Association of RGS2 and RGS5 variants with schizophrenia symptom severity. Schizophr Res (2008) 0.94
Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha. Neuropsychopharmacology (2004) 0.93
What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology. Nagoya J Med Sci (2013) 0.92
Deletion of PLCB1 gene in schizophrenia-affected patients. J Cell Mol Med (2012) 0.91
A recombination hotspot in a schizophrenia-associated region of GABRB2. PLoS One (2010) 0.90
Genome-wide association study of treatment refractory schizophrenia in Han Chinese. PLoS One (2012) 0.90
Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb Cortex (2009) 0.90
Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex. Neuroscience (2006) 0.89
MEGF10 association with schizophrenia. Biol Psychiatry (2008) 0.89
Schizophrenia: an integrative approach to modelling a complex disorder. J Psychiatry Neurosci (2006) 0.89
Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes? Genes Brain Behav (2010) 0.88
Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia. Schizophr Bull (2007) 0.88
Apoptotic engulfment pathway and schizophrenia. PLoS One (2009) 0.86
Dysbindin regulates the transcriptional level of myristoylated alanine-rich protein kinase C substrate via the interaction with NF-YB in mice brain. PLoS One (2010) 0.86
Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia. Schizophr Res (2008) 0.86
Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups. Pharmacol Biochem Behav (2008) 0.85
Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics. Brain Res (2010) 0.84
Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levels. Mol Pharmacol (2012) 0.84
Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models. Neuroscience (2011) 0.84
Can RGS4 polymorphisms be viewed as credible risk factors for schizophrenia? A critical review of the evidence. Schizophr Bull (2006) 0.82
RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample. Schizophr Bull (2009) 0.82
Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Med Genet (2010) 0.82
Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment. Psychopharmacology (Berl) (2012) 0.81
Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl inositol-protein kinase C signaling. Psychopharmacology (Berl) (2008) 0.81
Association of RGS4 variants with schizotypy and cognitive endophenotypes at the population level. Behav Brain Funct (2008) 0.81
Controlling Parasympathetic Regulation of Heart Rate: A Gatekeeper Role for RGS Proteins in the Sinoatrial Node. Front Physiol (2012) 0.80
Dopaminergic intracellular signal integrating proteins: relevance to schizophrenia. Dialogues Clin Neurosci (2006) 0.79
RGS4 genotype is not associated with antipsychotic medication response in schizophrenia. J Neural Transm (Vienna) (2006) 0.79
Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort. J Psychiatr Res (2013) 0.79
Genetics of developmental psychiatric disorders: pathways to discovery. J Psychiatry Neurosci (2005) 0.79
FBXL21 association with schizophrenia in Irish family and case-control samples. Am J Med Genet B Neuropsychiatr Genet (2008) 0.79
From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. Front Neurosci (2016) 0.77
Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine. PLoS One (2013) 0.76
Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury. J Pharmacol Exp Ther (2016) 0.76
Selective genomic targeting by FRA-2/FOSL2 transcription factor: regulation of the Rgs4 gene is mediated by a variant activator protein 1 (AP-1) promoter sequence/CREB-binding protein (CBP) mechanism. J Biol Chem (2011) 0.76
One Decade Later: What has Gene Expression Profiling Told us About Neuronal Cell Types, Brain Function and Disease? Curr Genomics (2009) 0.75
Contribution of nonprimate animal models in understanding the etiology of schizophrenia. J Psychiatry Neurosci (2011) 0.75
Developing therapeutics for schizophrenia and other psychotic disorders. NeuroRx (2005) 0.75
Association between RGS4 variants and psychotic-like experiences in nonclinical individuals. Eur Arch Psychiatry Clin Neurosci (2016) 0.75
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Testing for an unusual distribution of rare variants. PLoS Genet (2011) 9.28
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci (2008) 8.14
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet (2008) 6.72
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet (2005) 4.91
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci (2003) 4.86
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes (2005) 4.31
Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell (2005) 4.25
Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet (2009) 4.22
Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci (2007) 4.06
Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J (2002) 3.99
On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am J Hum Genet (2008) 3.95
A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
The future of psychiatry as clinical neuroscience. Acad Med (2009) 3.31
Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. J Low Genit Tract Dis (2015) 3.30
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 3.26
Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet (2005) 3.24
Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry (2008) 3.16
Discovering genetic ancestry using spectral graph theory. Genet Epidemiol (2010) 3.03
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell (2013) 2.94
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol (2006) 2.93
Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. Am J Psychiatry (2007) 2.84
Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr (2002) 2.84
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull (2008) 2.81
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis (2008) 2.76
A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71
Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci (2007) 2.70
Screen and clean: a tool for identifying interactions in genome-wide association studies. Genet Epidemiol (2010) 2.70
Common genetic variants, acting additively, are a major source of risk for autism. Mol Autism (2012) 2.67
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet (2008) 2.63
The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61
Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet (2004) 2.58
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry (2014) 2.46
Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron (2013) 2.45
Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33
Conflict of interest. Am J Psychiatry (2006) 2.30
Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry (2011) 2.28
Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci (2006) 2.23
Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst (2006) 2.21
Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci (2003) 2.18
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci (2005) 2.18
Association studies for quantitative traits in structured populations. Genet Epidemiol (2002) 2.13
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg (2013) 2.05
Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum Mol Genet (2005) 2.04
Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol (2008) 2.04
Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology (2008) 1.93
Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry (2011) 1.91
Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90
How the timing and quality of early experiences influence the development of brain architecture. Child Dev (2010) 1.87
Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep (2010) 1.87
Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol (1985) (2007) 1.86
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One (2013) 1.83
C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol (2004) 1.81
HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol (2008) 1.80
Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet (2010) 1.79
Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry (2008) 1.79
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics (2007) 1.78
Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex (2002) 1.77
Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet (2005) 1.77
Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J Neurosci (2005) 1.76
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest (2009) 1.75
The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74